Skip to main content

Table 3 Assessment of TEG at different time points

From: Does subcutaneous administration of recombinant human erythropoietin increase thrombotic events in total hip arthroplasty? A prospective thrombelastography analysis

Indexes Time points rHu-EPO group (n = 74) Control group (n = 78) P value
R(min) Pre-op
POD1
POD7
5.95 ± 1.71
5.73 ± 2.04
5.49 ± 1.39
5.98 ± 1.37
5.62 ± 1.48
5.66 ± 1.14
0.886
0.695
0.403
K(min) Pre-op
POD1
POD7
2.12 ± 0.77
2.11 ± 1.08
1.77 ± 0.47
2.39 ± 1.05
2.31 ± 1.27
1.60 ± 0.65
0.072
0.283
0.069
Alpha(°) Pre-op
POD1
POD7
59.61 ± 6.36
63.03 ± 10.65
66.01 ± 7.31
59.05 ± 11.05
61.77 ± 10.73
66.80 ± 8.67
0.704
0.468
0.545
MA(mm) Pre-op
POD1
POD7
60.08 ± 5.77
57.31 ± 7.46
64.10 ± 2.13
59.01 ± 5.67
58.37 ± 6.17
65.11 ± 7.88
0.254
0.341
0.286
CI Pre-op
POD1
POD7
− 0.43 ± 1.54
− 0.48 ± 3.42
0.73 ± 0.63
− 0.66 ± 2.86
− 0.32 ± 2.70
0.90 ± 2.00
0.540
0.746
0.492
  1. *P < 0.05, Pre-op pre-operation, POD1 postoperative day 1, POD7 postoperative day 7, R reaction time, MA maximum amplitude, CI coagulation index